Ashley Gallagher

The Signos Glucose Monitoring System uses body signals that help to improve sleep, manage weight, and decrease the risk of chronic disease.

Discover effective over-the-counter solutions for menstrual cramps, including NSAIDs and alternative therapies, to alleviate pain and discomfort.

Chronic pain affects many older adults, highlighting the need for safe acetaminophen use and effective pain management strategies.

Currently, systemic estrogen replacement therapy is contraindicated for women who have a history of ischemic stroke due to the risk of stroke recurrence.

New clinical trial results reveal upadacitinib's effectiveness in achieving significant hair regrowth for patients with severe alopecia areata.

Simultaneous vaccination with IIV4 and PPSV23 proves safe and effective for patients with chronic diseases, matching results of healthy individuals.

Recent studies reveal that while diabetes technology use rises, glycemic control in type 1 diabetes patients remains low, highlighting significant disparities.

Pharmacies face significant challenges in filling buprenorphine prescriptions for telemedicine patients, impacting opioid use disorder treatment access and patient satisfaction.

DTC pharmacies offer significant savings on total medication costs for neurological drugs, but out-of-pocket expenses remain high for insured patients.

Investigators found that Opill increased access for patients who were uninsured, identified as Black or Latina, had lower education, and lived in the Southern United States.

Pharmacists leverage socioeconomic insights to combat health disparities, enhancing access to medications and public health services in underserved communities.

Cyclobenzaprine HCl sublingual tablets (Tonmya) are the first new FDA-approved therapy for fibromyalgia in over 15 years.

FDA approves Wegovy for treating metabolic dysfunction–associated steatohepatitis, marking a breakthrough in liver health management and patient care.

As pharmacies face mounting challenges from changing reimbursement models, understanding and managing revenue cycles has never been more critical.

Pharmacists and dietitians acknowledge that older adults and patients with misconceptions about or poor knowledge of diet should be screened for interventions.

Adolescents often are at higher risk of unwanted pregnancy, unsafe abortion, and sexually transmitted infections due to inadequate knowledge of protective practices.

Experts discuss how pharmacists can successfully navigate value-based care models, overcome operational barriers, and generate new revenue streams.

Investigators find a large burden of hospitalization due to community-acquired pneumonia (CAP) for adults in the US, mainly caused by Streptococcus pneumoniae.

Vaccines prevent millions of deaths annually, and pharmacists play a crucial role in combating misinformation and enhancing community immunization access.

Investigators found that health care costs rose despite the benefits seen with starting semaglutide for patients with and without diabetes.

Although stroke is not common in pregnancy or childbearing years, pregnancy can increase the risk.

Less than 1 in 3 patients can very or extremely accurately predict when they will experience symptoms on a given day.

Investigators find modest improvements in body weight at week 26 for CT-868 compared with the placebo.

With more than half the population struggling to access medical care, community pharmacies are emerging as unexpected heroes in the health care delivery system.

Fremanezumab-vfrm (Ajovy) receives FDA approval for the prevention of episodic migraine for patients aged 6 to 17 years.

New research shows metformin's inconsistent neuroprotective effects against Alzheimer disease, challenging its role in diabetes management for cognitive health.

FDA approves Biktarvy for HIV treatment in patients not virologically suppressed, enhancing options for those restarting antiretroviral therapy.

In the study, tirzepatide (Mounjaro) improved measures of A1c, weight, renal function, and all-cause mortality.

The FDA also recommended a scheduling action for 7-hydroxymitragynine (7-OH), with data showing the drug binds to opioid receptors.

Novavax’s H5N1 avian influenza vaccine candidate shows a robust immune response with 1- and 2-dose intranasal or intramuscular administration for nonhuman primates.